Adipose-derived stem cells induced dendritic cells undergo tolerance and inhibit Th1 polarization

Cellular Immunology

Volumn 278, Issue 1-2, 2012, Pages 152-157

  Peng, Wei ^a,b   Gao, Tianjun ^b   Yang, Zai Liang ^a   Zhang, Shi Chang ^a   Ren, Ming Liang ^a   Wang, Zheng Guo ^a   Zhang, Bo ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Adipose derived stem cells; Dendritic cells; Th1 polarization; Tolerance

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE DERIVED STEM CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCULTURE; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; UPREGULATION; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-12; MIDDLE AGED; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868291741     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.07.008     Document Type: Article

References (40)

1. Nakagami H., Morishita R., Maeda K., Kikuchi Y., Ogihara T., Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J. Atheroscler. Thromb. 2006 Apr, 13(2):77-81.
2. A. Schaffler, C. Buchler. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007 Apr; 25(4):818-827.
3. Kamada Y., Yoshida Y., Saji Y., Fukushima J., Tamura S., Kiso S., et al. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice. Am. J. Physiol. 2009 Feb, 296(2):G157-G167.
4. Liang L., Ma T., Chen W., Hu J., Bai X., Li J., et al. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol. Res. 2009 Aug, 39(8):822-832.
5. Ning H., Liu G., Lin G., Garcia M., Li L.C., Lue T.F., et al. Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation 2009 Feb, 77(2):172-180.
6. Marcus A.J., Coyne T.M., Rauch J., Woodbury D., Black I.B. Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane. Differentiation 2008 Feb, 76(2):130-144.
7. Moon M.H., Kim S.Y., Kim Y.J., Kim S.J., Lee J.B., Bae Y.C., et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell. Physiol. Biochem. 2006, 17(5-6):279-290.
8. A.J. Thrasher. New insights into the biology of Wiskott-Aldrich syndrome (WAS). Hematology (Am. Soc. Hematol. Educ. Program) 2009:132-8.
9. Krauss A.C., Kamani N.R. Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. Bone Marrow Transplant. 2009 Aug, 44(3):137-143.
10. Mattson M.R. Graft-versus-host disease: review and nursing implications. Clin. J. Oncol. Nurs. 2007 Jun, 11(3):325-328.
11. J.M. Van Laar, A. Tyndall. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control 2003 Jan-Feb;10(1):57-65.
12. Ahmed N., Leung K.S., Rosenblatt H., Bollard C.M., Gottschalk S., Myers G.D., et al. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biol. Blood Marrow Transplant. 2008 Nov, 14(11):1298-1304.
13. Riley R.S., Idowu M., Chesney A., Zhao S., McCarty J., Lamb L.S., et al. Hematologic aspects of myeloablative therapy and bone marrow transplantation. J. Clin. Lab. Anal. 2005, 19(2):47-79.
14. Alaez C., Loyola M., Murguia A., Flores H., Rodriguez A., Ovilla R., et al. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity. Autoimmun. Rev. 2006 Mar, 5(3):167-179.
15. de Buys P., Khanna D., Furst D.E. Hemopoietic stem cell transplantation in rheumatic diseases-an update. Autoimmun. Rev. 2005 Sep, 4(7):442-449.
16. Snowden J.A., Passweg J., Moore J.J., Milliken S., Cannell P., Van Laar J., et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J. Rheumatol. 2004 Mar, 31(3):482-488.
17. Heller L., Cole P., Kaufman Y. Cheek reconstruction: current concepts in managing facial soft tissue loss. Semin. Plast. Surg. 2008 Nov, 22(4):294-305.
18. Penington A.J., Craft R.O., Tilkorn D.J. Plastic surgery management of soft tissue loss in meningococcal septicemia: experience of the Melbourne Royal Children's Hospital. Ann. Plast. Surg. 2007 Mar, 58(3):308-314.
19. S. Malikov, P.E. Magnan, D. Casanova, M. Lepantalo, N. Valerio, R. Ayari, et al. Bypass flap reconstruction, a novel technique for distal revascularization: outcome of first 10 clinical cases. Ann. Vasc. Surg. 2009 Nov-Dec;23(6):745-52.
20. Kanchwala S.K., Glatt B.S., Conant E.F., Bucky L.P. Autologous fat grafting to the reconstructed breast: the management of acquired contour deformities. Plast. Reconstr. Surg. 2009 Aug, 124(2):409-418.
21. Yaremchuk M.J., Kahn D.M. Periorbital skeletal augmentation to improve blepharoplasty and midfacial results. Plast. Reconstr. Surg. 2009 Dec, 124(6):2151-2160.
22. Maas C.S., Bapna S. Pins and needles: minimally invasive office techniques for facial rejuvenation. Facial Plast. Surg. 2009 Nov, 25(4):260-269.
23. Yeh C.C., Williams E.F. Fat management in lower lid blepharoplasty. Facial Plast. Surg. 2009 Nov, 25(4):234-244.
24. Papadopoulos O., Karypidis D., Moustaki M., Chrisostomidis C., Grigorios C., Epaminondas K., et al. Double scalping flap: a versatile technique in scalp reconstruction. J. Craniofac. Surg. 2009 Sep, 20(5):1484-1491.
25. A.M Altman, Y. Yan, N. Matthias, X. Bai, C. Rios, A.B. Mathur, et al. IFATS collection: Human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells 2009 Jan; 27(1):250-8.
26. L. Conti, E. Cattaneo. Novel and immortalization-based protocols for the generation of neural CNS stem cell lines for gene therapy approaches. Methods Mol. Biol. 2008;438:319-32.
27. Anisimov S.V., Christophersen N.S., Correia A.S., Li J.Y., Brundin P. "NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells. BMC Genomics 2007, 8:46.
28. Lin G., Garcia M., Ning H., Banie L., Guo Y.L., Lue T.F., et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008 Dec, 17(6):1053-1063.
29. Meliga E., Strem B.M., Duckers H.J., Serruys P.W. Adipose-derived cells. Cell Transplant. 2007, 16(9):963-970.
30. Cousin B., Ravet E., Poglio S., De Toni F., Bertuzzi M., Lulka H., et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE 2009, 4(7):e6278.
31. J.K. Fraser, M. Zhu, I. Wulur, Z. Alfonso. Adipose-derived stem cells. Methods Mol. Biol. 2008;449:59-67.
32. Valina C., Pinkernell K., Song Y.H., Bai X., Sadat S., Campeau R.J., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 2007 Nov, 28(21):2667-2677.
33. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., et al. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009 Feb, 126(2):220-232.
34. Bochev I., Elmadjian G., Kyurkchiev D., Tzvetanov L., Altankova I., Tivchev P., et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol. Int. 2008 Apr, 32(4):384-393.
35. Ma J., Shi M., Li J., Chen B., Wang H., Li B., et al. Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury. Haematologica 2007 Jul, 92(7):889-896.
36. Najar M., Rouas R., Raicevic G., Boufker H.I., Lewalle P., Meuleman N., et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy 2009, 11(5):570-583.
37. Bernardo M.E., Avanzini M.A., Ciccocioppo R., Perotti C., Cometa A.M., Moretta A., et al. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy 2009, 11(7):825-836.
38. Martins A.A., Paiva A., Morgado J.M., Gomes A., Pais M.L. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transpl. Proc. 2009 Apr, 41(3):943-946.
39. Kastrinaki M.C., Papadaki H.A. Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications. Curr. Stem Cell Res. Ther. 2009 Jan, 4(1):61-69.
40. Noel D., Caton D., Roche S., Bony C., Lehmann S., Casteilla L., et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell. Res. 2008, 314:1575-1584.